Core Insights - Green Dot Corporation (GDOT) is scheduled to report its third-quarter 2025 results on November 10, with a history of earnings surprises, having surpassed the Zacks Consensus Estimate in three of the last four quarters, averaging an earnings surprise of 42.1% [1] Q3 Expectations - The consensus estimate for GDOT's revenues is $487.3 million, reflecting a 20% year-over-year growth, primarily driven by robust performance in B2B services, which is expected to generate revenues of $363.2 million, indicating a 31% year-over-year increase [2] - The bottom line is projected to show a loss of 11 cents per share, contrasting with earnings of 13 cents in the same quarter last year [3] Earnings Prediction Model - The current model does not indicate a definitive prediction for an earnings beat for GDOT, as it has an Earnings ESP of 0.00% and a Zacks Rank of 4 (Sell), which does not support the likelihood of an earnings surprise [4][8]

Core Viewpoint - A proposed class action lawsuit claims that Tempus AI misled investors regarding its trading value and AI capabilities, concealing weaknesses in its operations and revenue outlook [1] Group 1: Lawsuit Details - The lawsuit was filed in the U.S. District Court for the Northern District of Illinois [1] - A report from a short-selling firm on May 28 accused Tempus of exaggerating its AI-driven revenue and questioned the backgrounds of its executives [1] Group 2: Stock Performance - Following the allegations, Tempus's stock price dropped over 19% on the same day, closing at $53.20 [1] - This decline represents the largest single-day drop in the company's stock price since its IPO in June 2024 [1]

Core Viewpoint - IQVIA Holdings Analytics Inc. reported strong first-quarter 2025 results, with earnings and revenues exceeding expectations, indicating positive growth trends in its business segments [1][7]. Financial Performance - Adjusted earnings were $2.70 per share, surpassing the Zacks Consensus Estimate by 2.7% and increasing 6.3% year-over-year [1]. - Total revenues reached $3.8 billion, exceeding the consensus estimate by 1.6% and growing 2.5% from the previous year [1]. - Adjusted EBITDA for the quarter was $883 million, a 2.4% increase from the year-ago quarter, but slightly below projections [5]. Segment Performance - The Research and Development segment generated revenues of $2.1 billion, showing a marginal increase year-over-year and meeting estimates [3]. - Revenues from the Technology and Analytics segment were $1.5 billion, growing 6.4% year-over-year and meeting estimates [4]. - Contract Sales and Medical Solutions revenues decreased 4.2% year-over-year to $181 million, missing estimates [4]. Cash Flow and Debt - Net cash generated from operating activities was $586 million, with capital expenditures of $142 million, resulting in a free cash flow of $426 million [6]. - The company ended the quarter with cash and cash equivalents of $1.7 billion, unchanged from the previous quarter, while long-term debt increased to $13.1 billion [5]. 2025 Guidance - For 2025, IQVIA raised its revenue guidance to $16.00-$16.40 billion, higher than the previous estimate and the Zacks Consensus Estimate of $15.86 billion [7]. - The company expects adjusted EPS in the range of $11.70-$12.10, with the midpoint exceeding the Zacks Consensus Estimate of $11.84 [7]. - Adjusted EBITDA guidance for 2025 is set at $3.76-$3.88 billion [7].